About this trial
Acute pain after breast surgery can significantly reduce the quality of life for patients. If acute pain is not adequately treated, it can develop into chronic pain. Thoracic epidural analgesia, thoracic paravertebral block, erector spinae plane block, and serratus anterior plane block are frequently applied blocks. However, ESPB, being a fascial plane block, can yield inconsistent results regarding distribution and dermatomal area. In recent years, there has been an increase in publications applying ESPB from two levels to achieve wider distribution. As a result, this study aims to compare the analgesic efficacy of single-level (Thoracic 3) and two-level (Thoracic 2, Thoracic 4) ESPB applications.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 18 and 80 years
American Society of Anesthesiologists physical status I-II-III
Body mass index between 18 and 30 kg/m²
Patients undergoing elective breast surgery
Disqualifiers
Patient refusing the procedure
History of chronic analgesic or opioid therapy
History of local anesthetic allergy
Infection in the intervention area
Trial design
Parallel
Treatments tested in this trial
One-level Erector Spinae Plane Block
Procedure/SurgeryOne-level Erector Spinae Plane Block will be performed unilaterally, under US guidance, before the surgical operation, and when the patient is placed in the lateral decubitus position. In applications, 30 ml of 0.25% bupivacaine will be injected at the T3 level.
Bi-level Erector Spinae Plane Block
Procedure/SurgeryBi-level Erector Spinae Plane Block will be performed unilaterally, under US guidance, before the surgical operation, and when the patient is placed in the lateral decubitus position. In applications, 15 ml of 0.25% bupivacaine at T2 level and 15 ml of 0.25% bupivacaine at T4 level will be injected.
Treatment groups
Trial outcomes
Primary outcomes
Pain scores
Pain will be assessed at the 4th-hour rest using the visual analog scale on a scale from 0 mm (no pain) to 100 mm (worst pain).
Secondary outcomes
Pain scores
Pain will be assessed at rest using the visual analog scale on a scale from 0 mm (no pain) to 100 mm (worst pain). Pain assessment will be done at the 1st, 2nd, 12th, and 24th hours after surgery.
Pain scores
Pain will be assessed while coughing using the visual analog scale on a scale from 0 mm (no pain) to 100 mm (worst pain). Pain assessment will be done at the 1st, 2nd, 6th, 12th, and 24th hours after surgery.
Tramadol Consumption
Postoperative intravenous tramadol infusion therapy will be administered with the patient-controlled analgesia (PCA) method. Thanks to PCA, how much morphine the patient needs will be followed in mg.
Side effects
Side effects, such as allergy to local anesthetics, hypotension, nausea/vomiting, and itching, will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.